Curasight News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Curasight. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Curasight Today - Breaking & Trending Today

Curasight announces acceleration of therapeutic strategy to strengthen position as a radiopharmaceutical theranostic company

/PRNewswire/ Curasight A/S ("Curasight" or the "Company" (XSAT: CURAS) announces today that it is accelerating and expanding its clinical therapeutic. ....

Ulrich Krasilnikoff , Curium Inc , Curasight Press , Coming Phase , Press Release ,

Curasight A/S Achieves First Milestone under collaboration with Curium Inc.

USD 500.000 payment is the first milestone under the global license and collaboration agreement for the development and commercialization of uTRACE® for use in. ....

United States , Ulrich Krasilnikoff , Curium Inc , Drug Administration , Curium First ,

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague

/PRNewswire/ Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) announces today that the previously announced results from the. ....

Czech Republic , Aleena Azam , Ulrich Krasilnikoff , World Molecular Imaging Congress , University Of Copenhagen , Primary Gliomas , Prognostic Value , Targeted Radionuclide , Molecular Imaging , Springer Publisher , Positron Emissions Tomography , Radionuclide Therapy ,

Curasight A/S reports positive preclinical results with uTREAT® in aggressive brain cancer (glioblastoma)

/PRNewswire/ Curasight A/S ("Curasight" or "the Company" - TICKER: CURAS) is pleased to announce preclinical data demonstrating the effectiveness of uTREAT®. ....

Ulrich Krasilnikoff ,

Curasight to present at HC Andersen Capital and Økonomisk Ugebrev

Copenhagen, Denmark, 26 May 2023 - Curasight A/S hereby announces that CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the company s Interim Report Q1 2023 at HC. | May 26, 2023 ....

Ulrich Krasilnikoff , Curasightas Curasight , Andreas Kj , Life Science Investor Conference , Positron Emissions Tomography , Curasightas Stock Exchange , Press Release , T Curas Dk0061295797 ,